AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29419934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafamostat mesilate (NM) at 0.25 mg/kg/h during IHD
Number of subjects: 18
Study 29419934 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) during IHD
Number of subjects: 18
Study 26857683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention programme including one initial session and six group sessions focused on self-management of pain, healthy behaviours, and educational interventions.
Number of subjects: 0
Study 26857683 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified, but implied to be standard care or no intervention.
Number of subjects: 0
Study 24309219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen, 800 mg given 60-90 min preprocedure
Number of subjects: 94
Study 24309219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac, 60 mg given 30-60 min preprocedure
Number of subjects: 94
Study 22390958 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-k lenses fitted with computer assisted system
Number of subjects: 51
Study 19765954 — intervention group
Group type: EXPERIMENTAL
Intervention: L-glutamine (0.5 g kg(‐1) d(‐1))
Number of subjects: 30
Study 19765954 — intervention group
Group type: COMPARATOR
Intervention: Calcium caseinate
Number of subjects: 30
Study 18380208 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone butyrate 0.1% lotion
Number of subjects: 284
Study 18380208 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 284
Study 15782288 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosa roxburghii supplementation
Number of subjects: 36
Study 15782288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11792135 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg daily
Number of subjects: 19768
Study 11792135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19768
Study 10088589 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day/week program
Number of subjects: 113
Study 10088589 — intervention group
Group type: COMPARATOR
Intervention: 6-day/week program
Number of subjects: 113
Study 7670782 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN patches (0.2 mg/h)
Number of subjects: 42
Study 2188276 — intervention group
Group type: EXPERIMENTAL
Intervention: Aniracetam 1 g daily for 3 months
Number of subjects: 44
Study 2188276 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 44
Study 7148737 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms of inorganic chromium as chromic chloride
Number of subjects: 76
Study 7148737 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 76
Study 7148737 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented normal free-living subjects
Number of subjects: 76
Study 31997129 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress group
Number of subjects: 101
Study 31997129 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study 31740368 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 months
Number of subjects: 40
Study 31740368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28587649 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) plus standardised medical care (SMC)
Number of subjects: 0
Study 28587649 — intervention group
Group type: COMPARATOR
Intervention: Standardised medical care (SMC) alone
Number of subjects: 0
Study 26040499 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneously every 6 months
Number of subjects: 3420
Study 26040499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3420
Study 23522532 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal infiltration of 1.8 mL 4% articaine hydrochloride with 1:100,000 adrenaline at the canine and first molar
Number of subjects: 22
Study 23522532 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal infiltration at the second molar
Number of subjects: 22
Study 23522532 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections at adjacent sites (canine and first molar)
Number of subjects: 22
Study 23522532 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections at different sites of the mandible
Number of subjects: 22
Study 22142711 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot orthosis and short-foot exercise (FOSF)
Number of subjects: 28
Study 22142711 — intervention group
Group type: COMPARATOR
Intervention: Foot orthosis (FO)
Number of subjects: 28
Study 19861631 — intervention group
Group type: EXPERIMENTAL
Intervention: Iatrogenic hookworm infection
Number of subjects: 0
Study 19861631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17823909 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice for weight reduction
Number of subjects: 21
Study 17823909 — intervention group
Group type: COMPARATOR
Intervention: General healthy eating booklet
Number of subjects: 21
Study 15753142 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplements
Number of subjects: 0
Study 11413894 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy (specific drugs not mentioned)
Number of subjects: 0
Study 11413894 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 9503310 — intervention group
Group type: EXPERIMENTAL
Intervention: Wright card
Number of subjects: 44
Study 9503310 — intervention group
Group type: COMPARATOR
Intervention: Teller card
Number of subjects: 44
Study 8061095 — intervention group
Group type: COMPARATOR
Intervention: Control arm of a randomized controlled trial of a vaginal contraceptive sponge
Number of subjects: 163
Study 2725119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine dose adapted to daily cigarette consumption (n = 51)
Number of subjects: 100
Study 2725119 — intervention group
Group type: COMPARATOR
Intervention: Standardized nicotine dose (n = 49)
Number of subjects: 100
Study 1101847 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride
Number of subjects: 225
Study 1101847 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 225
Study 1101847 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 225
Study 1101847 — intervention group
Group type: COMPARATOR
Intervention: Control group (neurotic patients)
Number of subjects: 225
Study 1101847 — intervention group
Group type: COMPARATOR
Intervention: Control group (psychotic patients)
Number of subjects: 225
Study 30417593 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month theory-informed intervention (online video, telephone call, two text messages)
Number of subjects: 76
Study 30417593 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 76
Study 29151484 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine (3000 mg/day for 4 weeks)
Number of subjects: 20
Study 29151484 — intervention group
Group type: COMPARATOR
Intervention: Control group (no glucosamine)
Number of subjects: 20
Study 26485913 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group with transcutaneous acupoint electrical stimulation (TAES) combined with dexmedetomidine
Number of subjects: 108
Study 26485913 — intervention group
Group type: COMPARATOR
Intervention: Control group with dexmedetomidine only
Number of subjects: 108
Study 26485913 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group with TAES combined with dexmedetomidine
Number of subjects: 108
Study 23702674 — intervention group
Group type: EXPERIMENTAL
Intervention: Medifoam H
Number of subjects: 66
Study 23702674 — intervention group
Group type: COMPARATOR
Intervention: DuoDERM
Number of subjects: 66
Study 21477383 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (minimum 1 × 10^9 Lactobacillus fermentum (PCC®) per day)
Number of subjects: 99
Study 21477383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 18022173 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg/day)
Number of subjects: 945
Study 18022173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 945
Study 18022173 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate (0.5 mg/day)
Number of subjects: 945
Study 17561800 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet group (n = 32)
Number of subjects: 57
Study 17561800 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 57
Study 15230508 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutch Heart Health Community Intervention
Number of subjects: 1200
Study 15230508 — intervention group
Group type: COMPARATOR
Intervention: Control region
Number of subjects: 1200
Study 11840583 — intervention group
Group type: EXPERIMENTAL
Intervention: oral midazolam, 0.2 mg/kg as anesthetic premedication
Number of subjects: 88
Study 11840583 — intervention group
Group type: COMPARATOR
Intervention: saline (oral normal saline as premedication)
Number of subjects: 88
Study 9512243 — intervention group
Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from endometriosis patients
Number of subjects: 30
Study 9512243 — intervention group
Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from tubal factor patients
Number of subjects: 30
Study 9512243 — intervention group
Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from male factor patients
Number of subjects: 30
Study 9512243 — intervention group
Group type: COMPARATOR
Intervention: Earle's balanced salt solution (control)
Number of subjects: 30
Study 8154410 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1, 20 ng/kg/min for 6 hours
Number of subjects: 15
Study 8154410 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15
Study 8154410 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E1 and Placebo
Number of subjects: 15
Study 3401524 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg of ethanol
Number of subjects: 42
Study 3401524 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 ml/kg of ethanol
Number of subjects: 42
Study 3401524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31077827 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily (induction studies)
Number of subjects: 1157
Study 31077827 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily (maintenance study)
Number of subjects: 1157
Study 31077827 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (various dosages)
Number of subjects: 1157
Study 31077827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1157
Study 29405274 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine chemotherapy (1000 mg/m2, administered on days 1, 8, and 15 every 4 weeks for six cycles)
Number of subjects: 225
Study 29405274 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 225
Study 29405274 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine chemotherapy
Number of subjects: 225
Study 26804729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence quantity measurement on the cheek
Number of subjects: 24
Study 26804729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence quantity measurement on the chin
Number of subjects: 24
Study 26804729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence quantity
Number of subjects: 24
Study 26804729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence measurements on the chin
Number of subjects: 24
Study 26804729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence measurements on the cheek
Number of subjects: 24
Study 25062592 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy for individuals at clinical high risk (FFT-CHR), 18 sessions over 6 months
Number of subjects: 129
Study 25062592 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (EC), 3 sessions of family psychoeducation
Number of subjects: 129
Study 25062592 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy for individuals at clinical high risk (FFT-CHR)
Number of subjects: 129
Study 25062592 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (EC)
Number of subjects: 129
Study 22150341 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish
Number of subjects: 379
Study 22150341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study 20547106 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive levetiracetam (LEV) 20‐60mg/kg/day
Number of subjects: 98
Study 18993165 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine (2 g/day)
Number of subjects: 30
Study 18993165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16076146 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 g raw purple carrots (463 micromol of anthocyanins: 400 micromol acylated, 63 micromol nonacylated)
Number of subjects: 0
Study 16076146 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 g cooked purple carrots (357 micromol of anthocyanins: 308.5 micromol acylated, 48.5 micromol nonacylated)
Number of subjects: 0
Study 16076146 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g cooked purple carrots (714 micromol of anthocyanins: 617 micromol acylated, 97 micromol nonacylated)
Number of subjects: 0
Study 16076146 — intervention group
Group type: EXPERIMENTAL
Intervention: Acylated anthocyanins
Number of subjects: 0
Study 11818758 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 384
Study 11818758 — intervention group
Group type: COMPARATOR
Intervention: Classic Laryngeal Mask Airway (LMA)
Number of subjects: 384
Study 11818758 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PLMA and LMA
Number of subjects: 384
Study 10759325 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal using a similar competing response
Number of subjects: 26
Study 10759325 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal using a dissimilar competing response
Number of subjects: 26
Study 10759325 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study 8748431 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine, 20 mg/day
Number of subjects: 671
Study 1827284 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin plus vancomycin (PV)
Number of subjects: 150
Study 1827284 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin, colistin sulphate and vancomycin (GCV)
Number of subjects: 150
Study 7432323 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of immunoglobulins (Ig)
Number of subjects: 218
Study 7432323 — intervention group
Group type: COMPARATOR
Intervention: None (Control group)
Number of subjects: 218
Study 31344051 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anaesthesia (GA)
Number of subjects: 0
Study 31344051 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Anaesthesia (IA)
Number of subjects: 0
Study 31344051 — intervention group
Group type: COMPARATOR
Intervention: Regional Anaesthesia (RA)
Number of subjects: 0
Study 28025662 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-high Train-high (LH-TH)
Number of subjects: 14
Study 28025662 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-high (LH)
Number of subjects: 14
Study 28025662 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 24491403 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Age tool
Number of subjects: 3153
Study 24491403 — intervention group
Group type: EXPERIMENTAL
Intervention: Framingham REGICOR
Number of subjects: 3153
Study 24491403 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional medical advice)
Number of subjects: 3153
Study 23370492 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-Visual modality match condition
Number of subjects: 0
Study 23370492 — intervention group
Group type: COMPARATOR
Intervention: Auditory-Visual modality mismatch condition
Number of subjects: 0
Study 23370492 — intervention group
Group type: EXPERIMENTAL
Intervention: Modality manipulation
Number of subjects: 0
Study 21326220 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (branched-chain amino acids)
Number of subjects: 116
Study 21326220 — intervention group
Group type: COMPARATOR
Intervention: MDX (maltodextrin)
Number of subjects: 116
Study 21326220 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 116
Study 19374041 — intervention group
Group type: EXPERIMENTAL
Intervention: UrgoCell Start
Number of subjects: 0
Study 19374041 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgotul Start
Number of subjects: 0
Study 17473825 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 160
Study 15084995 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Boot Camp
Number of subjects: 91
Study 15084995 — intervention group
Group type: COMPARATOR
Intervention: Traditional childbirth education program
Number of subjects: 91
Study 12596613 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal detecting-bulb (TDB)
Number of subjects: 400
Study 12596613 — intervention group
Group type: COMPARATOR
Intervention: Capnography
Number of subjects: 400
Study 9665110 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg on alternate days for an average of 12 years)
Number of subjects: 0
Study 9665110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9665110 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 0
Study 7666075 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine plus cisplatin
Number of subjects: 612
Study 7666075 — intervention group
Group type: EXPERIMENTAL
Intervention: Vindesine plus cisplatin
Number of subjects: 612
Study 7666075 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 612
Study 2503432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 20 mg or more, oral administration three or four times a day
Number of subjects: 0
Study 2503432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) during maintenance therapy
Number of subjects: 0
Study 2503432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) under ergometric exercise conditions
Number of subjects: 0
Study 356350 — intervention group
Group type: EXPERIMENTAL
Intervention: SL 25 (active substance)
Number of subjects: 34
Study 356350 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 34
Study 29166829 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 0
Study 28131786 — intervention group
Group type: EXPERIMENTAL
Intervention: Buparlisib plus paclitaxel
Number of subjects: 158
Study 28131786 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 158
Study 26924018 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA, 20 min)
Number of subjects: 0
Study 26924018 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (2 mA, 20 min)
Number of subjects: 0
Study 26924018 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA, 20 min)
Number of subjects: 0
Study 24884613 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte-branched chain amino acid (EA) beverage
Number of subjects: 20
Study 24884613 — intervention group
Group type: COMPARATOR
Intervention: Electrolyte-carbohydrate (EC) beverage
Number of subjects: 20
Study 24884613 — intervention group
Group type: COMPARATOR
Intervention: Flavored water (FW) beverage
Number of subjects: 20
Study 22009509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) followed by buccal misoprostol (800 µg)
Number of subjects: 100
Study 22009509 — intervention group
Group type: COMPARATOR
Intervention: Buccal misoprostol (800 µg only)
Number of subjects: 100
Study 19545341 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvenous (TV) leads
Number of subjects: 78
Study 19545341 — intervention group
Group type: COMPARATOR
Intervention: Epicardial (Epi) leads
Number of subjects: 78
Study 17973181 — intervention group
Group type: EXPERIMENTAL
Intervention: myofeedback with ergonomic counseling (Mfb/EC)
Number of subjects: 79
Study 17973181 — intervention group
Group type: COMPARATOR
Intervention: ergonomic counseling alone (EC)
Number of subjects: 79
Study 15134766 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal following a saccade
Number of subjects: 0
Study 15134766 — intervention group
Group type: COMPARATOR
Intervention: Control conditions employed in the experiments
Number of subjects: 0
Study 11549432 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 91
Study 11549432 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 91
Study 9576155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical clamp compression
Number of subjects: 778
Study 9576155 — intervention group
Group type: COMPARATOR
Intervention: Hand applied pressure
Number of subjects: 778
Study 7820333 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day for 7 days
Number of subjects: 12
Study 7820333 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg after omeprazole treatment
Number of subjects: 12
Study 7820333 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 100 mg before omeprazole treatment
Number of subjects: 12
Study 3416848 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted (F) condition
Number of subjects: 6
Study 3416848 — intervention group
Group type: COMPARATOR
Intervention: Normal-diet (ND) condition
Number of subjects: 6
Study 29945656 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated recruitment and randomisation method
Number of subjects: 12681
Study 29945656 — intervention group
Group type: COMPARATOR
Intervention: Manual recruitment and randomisation method
Number of subjects: 12681
Study 28212163 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent multiple organ dysfunction syndrome (MODS)
Number of subjects: 2449